top of page
References
Where does the content on the ataxia.info portal come from?
The ataxia.info portal uses reliable sources such as PubMed, OMIM, and other academic references. Information from websites specializing in ataxias is also used.
Technical articles, websites, videos and other references on ataxias
Content curated by Márcio Galvão. Use the filters to find content of interest. Paginated table.
RefID | Ataxias Relacionadas | Título | URL | Autor | Data da publicação | Fonte |
|---|---|---|---|---|---|---|
0201 | Diversas | Individualized exergame training improves postural control in advanced degenerative spinocerebellar ataxia: A rater-blinded, intra-individually controlled trial | https://pubmed.ncbi.nlm.nih.gov/28365204/ | Cornelia Schatton et al | 06/2017 | PMC (PubMed Central)® |
0202 | Diversas | Video game-based coordinative training improves ataxia in children with degenerative ataxia | https://pubmed.ncbi.nlm.nih.gov/23115212/ | Winfried Ilg et al | 11/2012 | PMC (PubMed Central)® |
0203 | Diversas | Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias | https://pmc.ncbi.nlm.nih.gov/articles/PMC9953858/ | Alexandra F Putka, Juan P Mato, Hayley S McLoughlin | 02/2023 | PMC (PubMed Central)® |
0204 | Diversas | Management of the ataxias towards best clinical practice Third edition
| https://www.ataxia.org.uk/wp-content/uploads/2020/11/Ataxia_UK_Medical_Guidelines._Third_Edition._v3m_Dec_2016_-_updated_Sep_2019.pdf | AtaxiaUK | 2016 | AtaxiaUK |
0205 | Ataxia espinocerebelar tipo 17 (SCA17) | Spinocerebellar Ataxia Type 17 | https://www.ncbi.nlm.nih.gov/books/NBK1438/ | Yasuko Toyoshima et al | Last Update: 07/2022 | GeneReviews® |
0206 | Ataxia espinocerebelar tipo 17 (SCA17) | Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: A case report | https://pmc.ncbi.nlm.nih.gov/articles/PMC3475097/ | Troels Tolstrup Nielsen et al | 08/2012 | PMC (PubMed Central)® |
0207 | Ataxia espinocerebelar tipo 17 (SCA17) | Discovery of a new molecular pathway in spinocerebellar ataxia 17 | https://www.ataxia.org/scasourceposts/sca17-inpp5a/ | Sriram Jayabal, Ray Truant | 2020 | NAF (National Ataxia Foundation) |
0208 | Ataxia espinocerebelar tipo 17 (SCA17) | SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6 | https://www.nature.com/articles/5201018# | C H Zühlke et al | 07/2003 | Nature |
0209 | Ataxia espinocerebelar tipo 17 (SCA17) | SCA 17: Ataxia + Intellectual Deterioration | https://neuromuscular.wustl.edu/ataxia/domatax.html#ataxintell | Alan Pestronk, MD | ND | NEUROMUSCULAR DISEASE CENTER |
0210 | Ataxia espinocerebelar tipo 17 (SCA17) | Molecular Mechanisms and Therapeutics for SCA17 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6985407/ | Qiong Liu et al | 07/2019 | PMC (PubMed Central)® |
0211 | Ataxia espinocerebelar tipo 17 (SCA17) | # 607136 - SPINOCEREBELLAR ATAXIA 17; SCA17 | https://www.omim.org/entry/607136 | Cassandra L. Kniffin, contributor alopez | Last Update: 06/2022 | OMIM® - Online Mendelian Inheritance in Man |
0212 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia | https://pmc.ncbi.nlm.nih.gov/articles/PMC6709527/ | Andrea Cortese et al | 03/2019 | PMC (PubMed Central)® |
0213 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | RFC1 CANVAS / Spectrum Disorder | https://www.ncbi.nlm.nih.gov/books/NBK564656/ | Andrea Cortese et al | 11/2020 | GeneReviews® |
0214 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | Brain Structural Signature of RFC1-Related Disorder | https://pubmed.ncbi.nlm.nih.gov/34241918/ | Paula Camila A A P Matos et al | 11/2021 | PMC (PubMed Central)® |
0215 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | Cranial Nerve Thinning Distinguishes RFC1-Related Disorder from Other Late-Onset Ataxias | https://pubmed.ncbi.nlm.nih.gov/38291837/ | Camila C Lobo et al | 01/2024 | PMC (PubMed Central)® |
0216 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | Hypothalamic atrophy in CANVAS/RFC1 | https://pubmed.ncbi.nlm.nih.gov/40526300/ | Verena Miranda Souza et al | 06/2026 | PMC (PubMed Central)® |
0217 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | Pathogenic CANVAS-causing but not nonpathogenic RFC1 DNA/RNA repeat motifs form quadruplex or triplex structures | https://pmc.ncbi.nlm.nih.gov/articles/PMC10563062/ | Mohammad Hossein Abdi et al | 09/2023 | PMC (PubMed Central)® |
0218 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | AAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS Neurons | https://pmc.ncbi.nlm.nih.gov/articles/PMC10760133/ | Connor J Maltby et al | 12/2023 | PMC (PubMed Central)® |
0219 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia 'CANVAS' syndrome | https://pubmed.ncbi.nlm.nih.gov/25070514/ | Teddy Y Wu et al | 10/2014 | PMC (PubMed Central)® |
0220 | CANVAS (ataxia cerebelar, neuropatia e síndrome de arreflexia vestibular) | Cerebellar ataxia, neuropathy, vestibular areflexia syndrome: genetic and clinical insights | https://journals.lww.com/co-neurology/fulltext/2021/08000/cerebellar_ataxia%2C_neuropathy%2C_vestibular.13.aspx | Sullivan, Roisin et at | 2021 | Current Opinion in Neurology (Wolters Kluwer) |
Page 1 of 1
BEWARE OF FAKE NEWS AND PSEUDOSCIENCE
Pseudoscience is based on beliefs, practices, or theories that present themselves as scientific but don't conform to valid scientific methods . It's important for those with ataxia (or any other disease!) to stay well-informed and grounded in reality, always validating the information they read on social media without blindly believing fake news about miraculous treatments (and often paid ones—unfortunately, there are unscrupulous individuals who take advantage of the desperation and lack of knowledge of patients with serious illnesses to sell products and services not yet approved by regulatory agencies, or to charge a high price for still-experimental therapies).
EVIDENCE-BASED MEDICINE
When you receive information about a new medication or treatment for ataxia, talk to your neurologist to verify the information, and check if there is any registration of the study on clinicaltrials.gov.
Content translated with AI support. Please read the Disclaimer .
bottom of page